Company Overview of Huntsman Cancer Institute
Key Executives for Huntsman Cancer Institute
Chief Executive Officer and Director
Senior Vice President for Health Sciences
Senior Director of Clinical Affairs
Senior Director of Clinical Affairs and Executive Medical Director
Manager of Public Relations
Compensation as of Fiscal Year 2014.
Huntsman Cancer Institute Key Developments
Huntsman Cancer Institute Announces Board Appointments
Apr 29 14
Two internationally known scholars will join Huntsman Cancer Institute (HCI) at the University of Utah as early as September 1, 2014. Cornelia Ulrich, Ph.D., currently serving as a director of the National Center for Tumor Diseases (NCT) and department head at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, will assume a leadership role, serving as HCI's new senior director of population sciences, and her husband, Bruce A. Edgar, Ph.D., a professor and researcher at the German Cancer Research Center (DKFZ)-Center for Molecular Biology Heidelberg (ZMBH) Alliance, will head an HCI laboratory. Both have previously held faculty positions at the Fred Hutchinson Cancer Research Center in Seattle, Washington.
Huntsman Cancer Institute Appoints John Sweetenham as Senior Director of Clinical Affairs and Executive Medical Director, Effective from April 1, 2013
Mar 27 13
John Sweetenham, M.D., currently a Professor of Medicine at the University of California, San Diego, and Medical Director of the UCSD University of Nevada Cancer Institute, has been appointed Senior Director of Clinical Affairs and Executive Medical Director at Huntsman Cancer Institute (HCI), and Professor in the Department of Medicine, Division of Hematologic Oncology at the University of Utah after a national search. He will assume his post April 1, 2013. Sweetenham has served in various leadership capacities at academic medical centers across the country, including the Cleveland Clinic and the University of Colorado.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries